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Abstract
Background: We retrospectively analyzed 25 years of experiences with the button Bentall procedure in patients
with aortic root pathologies. Even though this procedure has become widespread, there are only a few very long
term follow-ups available in the clinical literature, especially regarding single surgeon results.
Methods: Between 1988 and 2013, a total of 147 patients underwent the Bentall procedure by the same surgeon.
Among them there were 62 patients with Marfan syndrome. At the time of the surgery the mean age was 46.5 ±
17.6 years. The impact of surgical experience on long-term survival was evaluated using a cumulative sum analysis
chart.
Results: The Kaplan-Meier estimated overall survival rates for the 147 patients were 91.8 ± 2.3 %, 84.3 ± 3.1 %, 76.3 ±
4.9 % and 59.5 ± 10.7 % at 1,5,10 and 20 years, respectively. Multivariate Cox regression analysis identified EuroSCORE II
over 3 % (OR 4.245, 95 % CI, 1.739–10.364, p = 0.002), acute indication (OR 2.942, 95 % CI, 1.158–7.480, p = 0.023), use of
deep hypothermic circulatory arrest (OR 3.267, 95 % CI, 1.283–8.323, p = 0.013), chronic kidney disease (OR 6.865, 95 %
CI, 1.339–35.189, p = 0.021) and early complication (OR 3.134, 95 % CI, 1.246–7.883, p = 0.015) as significant risk factors
for the late overall death. The survival rate for freedom from early complication was 94.3 ± 2.2 %, 88.0 ± 3.3 %, 82.9 ±
4.7 % and 69.2 ± 8.4 % at 1,5,10 and 20 years. The main pathological findings of the aortic wall were cystic medial
degeneration in 75 %, fibrosis in 6 %, atherosclerosis in 13 % and no pathological alteration in 6 % of the samples. The
overall survival rate was significantly lower in patients operated in first 15 years compared to patients operated in the
last decade (log-rank p = 0.011).
Conclusion: According to our long-term follow-up the Bentall operation provides an appropriate functional result by
resolving the lesions of the ascending aorta. Based on our results, 25–30 operations done is necessary to gain such a
level of confidence and experince to aquire better results on long-term survival. In addition, we discussed that there
were no co-morbidities affecting on the survival of Marfan patients and prophylactic aortic root replacement ensures
a longer survival among patients with Marfan syndrome.
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Background
Aortic root replacement procedures, which include the
modified version of the original Bentall [1] operation, the
“button Bentall procedure”, which is an open technique
for reattaching the coronary ostia. Although this proced-
ure has become widespread, there are only a few very
long term follow-ups available in the clinical literature.
We evaluated the long-term clinical outcomes and
sought to determine the independent predictors of long-
term mortality for the button Bentall procedure in 147
patients [2]. We analyzed the independent risk factors of
long-term mortality in a subdivided Marfan population
too. Furthermore, there has been no study published yet
about experience and results of a single surgeon in
Bentall procedure.* Correspondence: kalman.benke@gmail.com
1Heart and Vascular Center, Semmelweis University, H-1122 Városmajor str.
68, Budapest, Hungary
3Hungarian Marfan Foundation, Budapest, Hungary
Full list of author information is available at the end of the article
© 2016 Benke et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Benke et al. Journal of Cardiothoracic Surgery  (2016) 11:19 
DOI 10.1186/s13019-016-0418-y
Methods
Patients’ characteristics
We retrospectively analyzed 25 years of experience with
Bentall procedure. Between 1988 and 2013, a total of 147
patients who underwent aortic root reconstruction at the
Heart and Vascular Center, Semmelweis University. Of
these patients, 111 (75 %) were male and 36 were female
(25 %). 62 patients were with Marfan syndrome (42 %)
among them and the diagnosis of the syndrome was
verified in every case with the use of the original and later
the revised Ghent criteria [3]. Subanalysis of the Marfan
syndrome group was performed.
An electronic Aortic Root Reconstruction Registry data-
base has been established which includes demographics,
types of indications, comorbidities, procedure specifica-
tions and follow-up informations. Medical records and
patient’s history were used to identify comorbidities. Pa-
tients’ follow-ups included clinical examination, computed
tomography scans and transthoracic echocardiography,
and they were treated by the same surgeon. During the
studied period, Tirone David valve-sparing procedures
were performed in 27 patients. These patients were ex-
cluded from the study.
The mean patient age at the time of the operation was
46.3 ± 17.5 years (range, 8–78 years), 8 (5 %) patients were
older than 70 years. We measured body parameters of pa-
tients (height and weight), and calculated the Body Mass
Index. The mean BMI was 25.6 ± 5.6 kg/m2. We found
that 80 patients had hypertension (54 %), 11 patients had
diabetes mellitus (7 %) and 6 had hyperlipidaemia (4 %).
21 patients were suffering from coronary artery disease
(14 %) at the time of the operation, 4 from chronic kidney
disease (3 %) and 7 patients had cerebrovascular accident
(5 %). The cardiovascular functional status was deter-
mined according to the New York Heart Association
(NYHA). EuroSCORE II was calculated in all patients ac-
cording to the EuroSCORE II protocol [4]. The histology
of the aortic wall and valve were available in 114 patients
(78 %). The main indications of the operation were annu-
loaortic ectasia (61 %), acute aortic dissection (16 %) and
chronic aortic dissection (23 %). Preoperative variables are
depicted in Table 1.
Surgical technique
The operation was performed via median sternotomy,
and cardiopulmonary bypass was applied by cannulating
the ascending aorta, aortic arch, femoral artery, or axillar
artery, and the right atrium. Myocardial protection was
provided by anterograde, retrograde, or simultaneously
anterograde and retrograde intermittent cold hyperkale-
mic blood cardioplegia. Deep hypothermic circulatory
arrest (DHCA) was used in 28 patients (19 %). The cor-
onary buttons were excised with the aortic wall patch
and mobilized to facilitate reimplantation. The proximal
anastomosis was implemented with pledgeted interrupted
sutures. The distal, grafto-aortic anastomosis was accom-
plished with continuous sutures and the coronary button
anastomoses were also performed with continuous sutures.
St. Jude composite graft (St. Jude Medical, Inc., St.Paul,
MN, USA) was used in 101 patients; Carbomedics com-
posite graft (Carbomedics, Austin, TX, USA) in 16 pa-
tients; Carbomedics Carbo-Seal conduit (Sorin, Milano,
Italy) in 18 patients; Vascutek Gelweave composite graft
(Vascutek, Scotland, UK) in 5 patients; Hancock bio-
prosthesis (Medtronics, Minneapolis, Minnesota, USA)
with Vaskutek straight graft in 5 patients; and Shelhigh
bioconduit (Shelhigh, Union, NJ, USA) in 2 patients. The
7 bioprosthetic valve and graft were compiled together by
the surgeon during operation.
The concomitant procedures were performed in 39 pa-
tients (27 %); included mitral valve surgery in 11, coronary
artery bypass grafting (CABG) in 12, hemi- and total arch
replacement in 10, pacemaker implantation in 2, and others
in 4 patients. Operative data are described in Table 2.
Follow-up and statistical analysis
We selected all-cause mortality as the endpoint. No pa-
tient was lost during the follow-up period. Death was
detected from death records of the Hungarian National
Health Insurance Fund, which provided accurate mortality
data for every patient. Follow-up period for the overall
survival was measured from the date of the operation to
the date of death, or of last contact alive. Follow-up ended
on October 2013. 118 patients (80 %) of survivors had
Table 1 Preoperative characteristics
Preoperative variables n (%)
Patients 147
Age (yrs) ± SD 46.3 ± 17.5
Male/Female 111/36 (75/25)
Hypertension 80 (54)
Diabetes mellitus 11 (7)
Coronary artery disease 21 (14)
HLP 6 (4)
BMI (kg/m2) 25.6 ± 5.6
Cerebrovascular accident 7 (5)
Chronic kidney disease 4 (3)
NYHA class 1.3 ± 0.6
EuroSCORE II (%) 4 [2–6]
Aorta ascendens diameter (mm) 61.7 ± 16.3
Marfan syndrome 62 (42)
Previous Cardiac Operation 6 (4)
Grade of aortic regurgitation 2.8 ± 1.5
Ejection fraction (%) [before OP / after OP] 49.6 ± 8.3 / 54.33 ± 11.17
All-cause death 29 (20)
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completed follow-up. The mean length of the follow-up
periods was 84 ± 56 months.
All continuous variables were expressed as mean ± SD
or median with interquartile ranges, whereas categorical
variables were expressed as percentage. The Shapiro-
Wilk test was used to check the normality of the data
before further analysis. For the analysis of the data we
used Student’s t-test, Mann–Whitney U-test and χ2 test.
Univariate and multivariate analysis of predictors for
mortality were performed using a Cox regression model
evaluate the association between independent risk fac-
tors and mortality. Survival curves were created using
the Kaplan-Meier method and compared with the log-
rank test. Multivariate logistic regression analysis was
used to identify the risk factors of early complication.
We used univariate and multivariate Cox regression
analysis to evaluate the effect of comorbidities on mortal-
ity. Multivariate Cox regression identified the independent
risk factors of long-term mortality after Bentall procedure.
The determination of risk factors was carried out by
selecting variables with p < 0.10 from univariate Cox re-
gression, and further examined our data with multivariate
Cox regression analysis. A p-value of <0.05 was considered
statistically significant (Table. 4).
The impact of surgical experience on survival was evalu-
ated using a time-adjusted cumulative sum complication
chart. The statistical principles were adapted from the
comprehensive tutorial by Rogers et al. [5]. Cumulative
sum (CUSUM) analysis is defined as Sn = (Xi – p0i), where
Xi = 0 for operation without complication and 1 for the
presence of early complication, and p0i denotes the pre-
dicted probability of the development of early complication
within 30 days after surgery. The graph starts at zero, but is
incremented by 1- p0i for formation of early complication
and decremented by p0i for uncomplicated operation [6].
This graph is very descriptive because it moves upwards if
the complication rate increases above the risk model
predicted results, moves downwards if the rate decreases
and oscillates around zero performance which is consistent
with predicted risks thus is considered as acceptable [6].
Data were stored in Aortic Root Reconstruction Register
and analysed with the SPSS statistical program (version
20.0,Chicago, IL, USA).
Results
Early outcomes
The operative mortality was 2 %. The overall early
mortality rate, defined as death within 30 days of initial
hospitalization, was 3.4 % (5/147). Causes of early death
were low cardiac output syndrome (n = 1), diffuse hyp-
oxic brain damage (n = 2), ventricular arrhytmia (n = 1)
and excess bleeding in 1 patient. Early complications
included postoperative resternotomy for bleeding (n = 9),
atrial and ventricular arrhytmias (n = 13), renal failure
needing hemodialysis (n = 1), cerebral infarction (n = 2)
and pericardial tamponade (n = 1) (Table 3).
Multivariate logistic regression analysis revealed, that
NYHA class of III and IV (OR 9.2, 95 % CI, 0.972–87.240,
p = 0.050), dissection (OR 6.817, 95 % CI, 1.392–33.393,
p = 0.018), concomitant CABG surgery (OR 15.722,
95 % CI, 3.087–80.064, p = 0.001) and concomitant
Table 2 Operative data
Operative data n (%)
Aortic pathology
Annuloaortic ectasia 89 (61)
Dissection (acute/chronic) 24/34 (16/23)
Bicuspid aortic valve 11 (7)
Implanted valve type
Mechanical valve 140 (95)
Bioprosthetic valve 7 (5)
Composite valve size (mm) 25.9 ± 1.7
Comcomitant cardiac procedures
Mitral valve surgery 11 (7.5)
Coronary artery bypass 12 (8)
Total arch replacement 10 (7)
Pacemaker implantation 2 (1)
Others 4 (2)
Cardiopulmonary bypass
Operation time (min) 245 [210–305]
Cardiopulmonary bypass time (min) 155 [130–185]
Aortic cross-clamp time (min) 113 [100–137]
DHCA use 28 (19)
Pharyngeal temperature (̊C) 25.6 ± 6.1
Timing of operation
Emergency 24 (16)
Urgency 34 (23)
Table 3 Causes of complications
Complications n (%)
Intraoperative complications
Bleeding 7 (5)
Arrythmia 3 (2)
Early postoperative complications
Bleeding 9 (7)
Diffuse cerebral hypoxia 2 (1)
Pericardial tamponade 1 (0.7)
Renal failure needed hemodialysis 1 (0.7)
Arrythmia 13 (9)
Late postoperative complications
Bleeding 1 (0.7)
Arrythmia 2 (1)
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mitral valve surgery (OR 5.207, 95 % CI, 0.987–27.480,
p = 0.049) were the independent risk factors for early
complication, which defined as possible life-threathening
complication within 30 days of initial hospitalization
(Table 5).
Long-term results
The mean survival was 190 ± 10.3 months (IQ range:170–
210 months). There have been 23 late deaths (death after
one year), whereof 18 cardiac-related (78 %) and 5 non-
cardiac-related (22 %) deaths occured. The most common
causes of cardiac-related death were aneurysm rupture of
descending aorta, sudden cardiac death, congestive heart
failure, CVA and low cardiac output syndrome.
Kaplan-Meier estimated overall survival rates for the
147 patients (including deaths occured at the initial
hospitalization) were 91.8 ± 2.3 %, 84.3 ± 3.1 %, 76.3 ±
4.9 % and 59.5 ± 10.7 % at 1,5,10 and 20 years, respect-
ively (Fig. 1a). Multivariate Cox regression analysis iden-
tified EuroSCORE II over 3 % (OR 4.245, 95 % CI,
1.739–10.364, p = 0.002), acute indication (OR 2.942,
95 % CI, 1.158–7.480, p = 0.023), DHCA use (OR 3.267,
95 % CI, 1.283–8.323, p = 0.013), chronic kidney disease
(OR 6.865, 95 % CI, 1.339–35.189, p = 0.021), and early
complication (OR 3.134, 95 % CI, 1.246–7.883, p = 0.015)
as significant risk factors for the late overall death
(Table 6).
Influence of Marfan syndrome on survival
We have separated the patients into two groups: patients
with Marfan syndrome (Marfan group), and patients with-
out Marfan syndrome (non-Marfan group) (Table 4). Multi-
variate regression analysis of all patients’ data revealed, that
EuroSCORE II over 3 % (OR 5.612, 95 % CI, 1.761–17.884,
p = 0.004) and acute indication (OR 6.391, 95 % CI, 1.373–
29.750, p = 0.018) were the independent risk factors for
mortality (Table 5). Among the patients with Marfan syn-
drome, the overall survival rate did not reach statistical sig-
nificance (log rank p = 0.877) compared to the non-Marfan
group (Fig. 1b).
Outcome of dissections
Overall survival rate differed between the non-dissection
group and the dissection group. In the latter group the
results were significantly lower according to the log-rank
test (p = 0.031) (Fig. 2a). However in Marfan syndrome
patients with dissection, the overall survival rate tended to
decline compared to the dissection group without Marfan
syndrome and to the non-dissection group (Fig. 2b).
Histopathology of the aortic wall and valve
During the operation aortic wall and valve samples were
collected and sent for pathological examination. The
main pathological findings unearthed were cystic medial
degeneration (CMD) in 85 samples (75 %), fibrosis in 7
samples (6 %), atherosclerosis in 15 samples (13 %) and
no pathological alteration in 7 samples (6 %). Overall
survival rates between the patients with CMD, patients
with fibrosis and patients with atherosclerosis were simi-
lar (CMD vs. fibrosis log-rank p = 0.197; CMD vs. ath-
erosclerosis log-rank = 0.400; fibrosis vs. atherosclerosis
log-rank p = 0.876) Fig. 2.
Impact of surgical experience on survival
We have compared the first 15 years of results to the last
10 years of results to investigate the influence of surgical
Fig. 1 Kaplan-Meier estimated survival curves. Actual survival of all patients, at the mean follow-up time of 190 ± 10.3 months, following the Bentall
procedure (a). Actual survival of Marfan and non-Marfan syndrome patients (b)
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experience on survival. From 1998 till the end of 2003
42 patients were operated (29 %). The other 105 pa-
tients were operated at the next decade (71 %). The
overall survival rate was significantly lower in patients
operated in first 15 years compared to patients operated
in the last decade (log-rank p = 0.011) (Fig. 4a). The
time-adjusted CUSUM complication curve for the en-
tire follow-up time is illustrated in (Fig. 3b). The
CUSUM curve presents an upward inflection at the
first 27 operation, which indicates the major learning
curve effect. After that, we observed a downward in-
flection, indicating better results and the experience of
the surgeon with respect to the predicted complication
rates. Specially, we observed three complication be-
tween operations no. 121 and no. 124. This cluster of
complications necessitated a review. We found that
these patients were fragile, multimorbid and urgent
cases, than the other as evidenced by the higher pre-
dicted probability of complication.
Table 4 Risk factor analysis for late overall death
Variables Patients (n = 147) Patients with Marfan syndrome (n = 62)
Univariate Multivariate Univariate Multivariate
Age 0.821 0.584
Sex (male) 0.097 0.089 0.226
Hypertension 0.141 0.156
Diabetes mellitus 0.348 -
Hyperlipidaemia 0.577 0.787
BMI > 30 0.448 0.335
Coronary artery disease 0.167 0.390
Cerebrovascular accindent 0.505 0.682
Chronic kidney disease 0.011a 0.036a 0.683
EuroSCORE II > 3 (%) <0.0001a 0.002a <0.0001a 0.004a
Aortic diameter > 60 mm 0.211 0.369
Bicuspid aortic valve 0.538 -
Emergency 0.006a 0.023a 0.006a 0.018a
Combined mitral valve surgery 0.856 0.547
Combined CABG surgery 0.062 0.701
Combined with arch replacement 0.855 0.995
Ejection fraction < 50 % 0.681 0.252
LVESD 0.805 0.370
LVEDD 0.534 0.206
Dissection 0.035a 0.136 0.094 0.476
CPB time 0.002a 0.710 0.982
Operation time > 5 h 0.002a 0.224 0.102
DHCA use 0.004a 0.013a 0.597
Aortic cross-clamp time 0.753 0.800
Early complication 0.035a 0.015a 0.190
astatistically significant
Table 5 Independent predictors of late overall mortality in
multivariate cox regression analysis
Variables Patients (n = 147)
OR 95 % CI P-value
EuroSCORE II > 3 % 4.245 1.739–10.364 0.002
Emergency 2.942 1.158–7.480 0.023
DHCA use 3.267 1.283–8.323 0.013
Chronic kidney disease 6.865 1.339–35.189 0.021
Early complication 3.134 1.246–7.883 0.015
Patients with Marfan syndrome (n = 62)
OR 95 % CI P-value
EuroSCORE II > 3 5.612 1.761–17.884 0.004
Emergency 6.391 1.373–29.750 0.018
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Discussion
The mean survival in our study was 190 ± 10.3 months
(IQ range:170–210 months). There are only few papers
published about the Bentall procedure which include
mean follow-up duration of more than six years (Table 6).
In our study, we report that the independent predic-
tors of early complication include NYHA class of III and
IV, dissection and concomitant CABG or mitral valve
surgery. The poor cardiac condition might often associ-
ated with early arrythmias, while aortic dissection is a
well-known risk factor of the bleeding events.[7]
Numerous studies have shown different independent risk
factors for death after Bentall procedure [8, 9]. Advanced
age, dissection, Marfan syndrome, severe ventricular dys-
function, endocarditis, previous cardiac surgery, emergency
status, coronary artery disease, poor preoperative New York
Heart Association functional class and left ventricle ejection
fraction <35 % were known as predictors of early and late
death.[8, 9] We observed that late overall death was
strongly correlated with EuroSCORE II over 3 %, acute
indication, DHCA use, chronic kidney disease and early
complication thus all the above mentioned factors seem to
be independent risk factors of late mortality. In regard that
common causes of late death such as rupture of descendent
aorta aneurysm, sudden cardiac death, congestive heart fail-
ure, CVA, low cardiac output syndrome are associated with
poor NYHA status and complications [8]. We found that
in our research operative mortality and long-term survival
after Bentall surgery were comperable to that in other stud-
ies [2, 8, 10]. With improvements in operative technique
and postoperative management years, Marfan syndrome,
diabetes, hypertension, bicuspid aortic valve, hyperlipid-
aemia, coronary artery disease, cerebral vascular accident,
concomitant cardiac surgery, longer operation, aortic cross-
clamp time and dissection did not prove to be risk factors
for mortality in this study.
Fig. 2 Kaplan-Meier estimated survival curves. Actual survival rate for non-dissection and dissection patients (a). Actual survival of dissection with
Marfan syndrome (group 1), dissection without Marfan syndrome (group 2) and non-dissection (group 3) patients (b)
Fig. 3 Histological findings of the aortic wall. Cystic medial degeneration (a) in 75 %, fibrosis (b) in 6 %, atherosclerosis (c) in 13 % of the samples
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There are many debates as to whether Marfan syn-
drome had an influence in long-term survival after the
Bentall procedure. Although several papers have been
published [2, 8, 11], on the subject regarding the impact
of presence of Marfan syndrome on survival rate, but
only few of them studied the Marfan group as a separate
patient group. Since Marfan patients are usually oper-
ated in younger age and with less comorbidities [12],
therefore they should be managed as a distinct patient
group. We presented the risk factors of mortality of the
Marfan patients separately. In our study, EuroSCORE II
over 3 % and acute indication were significant predictors
of long-term mortality among patients with Marfan
syndrome. These results also confirm, that there were
no co-morbidities affecting the survival of Marfan pa-
tients. However the prevention of the acute, often life-
threatening complications – such as aortic dissection –
with prophylactic aortic root replacement ensures longer
survival among patients with Marfan syndrome [13].
There was a trend for decreased survival of patients with
Marfan syndrome in the course of time compared to that
of non-Marfan patients (Fig. 1b), but we could not find a
significant difference in long-term survival (p = 0.877) [14].
In our study acute or chronic dissection was the surgi-
cal indication in 58 cases. Overall survival rates among
the dissection groups were comparable to other re-
ports [11].
The long-term survival of the cardiac procedures are
examined from the perspective of the duration of the
operation [8]. In our series, thirty-six (24 %) patients had
a longer, than five hours operation time. The risk factors
of extended duration operations were NYHA class of III
and IV, dissection, concomitant mitral valve surgery and
DHCA use. According to these results, poor NYHA sta-
tus and the extension of the surgical area increases the
length of the surgery, thus patients with worse cardiac
status (EF:30-40 %) should be treated for precondition-
ing with inta-aortic balloon pump (IABP) or with 24 h
levosimendan infusion preoperatively.
Although we had incomplete data in 33 cases, histo-
logical differences has never been investigated in Bentall
studies. In our study, distribution of the histological type
were cystic medial degeneration (CMD) in 85 samples
(75 %), which is also known as the pathological change
of the aortic wall in Marfan patients [15]. Furthermore
there were fibrosis in 7 samples (6 %), atherosclerosis in
15 samples (13 %) and no pathological changes in 7 sam-
ples (6 %). The survival rates were not different compared
to each other among patients with abnormal histological
evidence. (CMD vs. fibrosis log-rank p = 0.197; CMD vs.
atherosclerosis log-rank = 0.400; fibrosis vs. atherosclerosis
log-rank p = 0.876) (Fig. 2).
During the cardiothoracic training surgeons need to
gain experience in Bentall procedure. Hence the surgeon
launches on a ‘learning curve’, and unfortunately, his/her
patients may possibly be at a higher risk [6]. The trad-
itional way of the surgical audit with retrospective analysis
of outcome data and statistical testing is an appropriate
method to estimate the learning curve. However, when
this is not the case the CUSUM curve is more suitable for
this kind of analysis [16]. Hence several publications have
used the CUSUM method to asses surgical results in
cardiac surgery [16, 17]. However we found no data about
the learning curve of the button Bentall procedure. In this
study single surgeon results were demonstrated, therefore
we could apply the time adjusted cusum complication
curve to this case (Fig. 4b). At the beginning the CUSUM
curve starts with an upward inflection, which indicates the
major learning curve effect. Based on our findings after 27
operations the risk of the early complications started to re-
duce. This reflects according to our findings, that approxi-
mately 25–30 operations are necessary to aquire better
results on survival. After that, we observed a downward
inflection, indicating better results and an increase in the
experience of the surgeon with respect to the predicted
complication rates. Subsequently, when the surgeon felt
confident with this procedure, he started to consider those
patients in worse condition suitable for Bentall surgery
and this may have resulted in a small assessment of the
curve (Fig. 4b).
Additionally, after comparing the first fifteen years of
surgical results to the last decade the overall survival
Table 6 Previous reports about Bentall operation
Author Patient group Follow-up Early complication
rate (%)
Long-term survival at
5/10/20 years (%)
Tae Sik Kim et al. [2] n = 195, 1997–2010, 47 patients with MFS median, 64 months 48.7 96/90/-
Patel et al. [21] n = 140 Marfan patients, 1997–2006 mean, 114 months 21.5 90/-/-
Gott et al. [20] n = 675 patients with MFS, 1968–1996 10 centers mean, 80 months - 84/75/-
Kouchoukos et al. [7] n = 168, 1974–1990, 30 patients with MFS mean, 81 months - 61 at 7 years/ 48 at 12 years/-
Joo et al. [11] n = 218, 1982-2010 mean, 108 months 48.1 83/78/-
Benke et al. n = 147, 1988–2013, 62 patients with MFS mean, 84 months 25.5 84/76/59
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rate we found that the results were significantly lower in
first 15 years operated group than the last 10 years oper-
ated group (log-rank p = 0.011) (Fig. 4a).
Our paper has some limitations that are unaviodable in a
retrospective study. Observational data do not provide cas-
ual evidence. After fifteen years of observation time only
10 % of of patients still at risk which is a limitation. Due to
incomplete data collection, several important variables,
such as ejection fraction after surgery and pharyngeal
temperature, were omitted in the statistical analysis. The
histology of the aortic wall could not be included in logistic
regression analysis due to the missing 33 samples. In our
study only two pseudoaneurysm formations was observed
at the graft anastomosis sites [18, 19], but none of them
were Marfan patient. The estimation of odds ratios, with
regard to chronic kidney disease (n = 4) and NYHA class of
III and IV in Marfan patients (n = 2), could not be carried
out in logistic regression analysis due to the low number of
events.
Conclusion
In summary, as this study was performed from the data of
one surgeon, gives us the opportunity to describe the learn-
ing curve of the button Bentall procedure and follow the
results through his course of carrier. In our series, 25–30
operations gave the surgeon confidence and experince to
aquire better results on long-term survival. In addition, we
discussed that there were no co-morbidities affecting on
the survival of Marfan patients and prophylactic aortic root
replacement ensures a longer survival among patients with
Marfan syndrome. Finally, upon the statistical results we
discussed histological changes of the aortic wall, which has
never been described in long-term button Bentall follow-
ups.
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Fig. 4 Actual survival of patients operated at the first fifteen years of follow-up and patients operated in the last decade (a). The risk-adjusted CUSUM
complication curve for the entire follow-up (b)
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